Concepedia

Katarzyna Wiklik

KW

Statistics

Publications

4

Citations

163

H-Index

4

Active since

2017

Affiliations

Merck KGaA, Darmstadt (Germany)(Current)

Katarzyna Wiklik is an author at Merck KGaA, Darmstadt (Germany) specializing in pharmacology, medicinal chemistry, and drug discovery.

ORCID

Publications per year

2017–2021

4

Publications

4

SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains

Tomasz Rzymski, Michał Mikuła, Eliza Żyłkiewicz et al. · Oncotarget · 2017 · 107 citations · Full text

, , +15

Synthesis of amide and sulfonamide substituted N-aryl 6-aminoquinoxalines as PFKFB3 inhibitors with improved physicochemical properties

Nicolas Boutard, Arkadiusz Białas, Aleksandra Sabiniarz et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 24 citations · Full text

, , +10

Discovery and Structure–Activity Relationships of <i>N</i>‐Aryl 6‐Aminoquinoxalines as Potent PFKFB3 Kinase Inhibitors

Nicolas Boutard, Arkadiusz Białas, Aleksandra Sabiniarz et al. · ChemMedChem · 2018 · 21 citations · Full text

, , +17

Release of adenosine-induced immunosuppression: Comprehensive characterization of dual A2A/A2B receptor antagonist

Katarzyna Dziedzic, Paulina Węgrzyn, Michał Gałȩzowski et al. · International Immunopharmacology · 2021 · 11 citations

, , +16

1–4 of 4